Toxicity differences inform decision on conditioning for neuroblastoma transplants

The stem cell transplant regimen that was commonly used in the United States to treat advanced neuroblastoma in children appears to be more toxic than the equally effective regimen employed in Europe and Egypt, according to a new study being presented at the 26th annual meeting of the American Society of Pediatric Hematology Oncology in Miami April ... (more)

http://www.eurekalert.org/pub_releases/2013-04/dci-odi042213.php